Data-Gouv-ML/pcri-informations-sur-les-projets-laureats huggingface dataset:
Demand Response Integration tEchnologies: unlocking the demand response potential in the distribution grid (DRIVE)

Framework: Horizon 2020 — Societal Challenges
Programme: Secure, clean and efficient energy
Theme: A single, smart European electricity grid
Action type: Research and Innovation actions
Countries involved: Spain,Italy,Spain,Serbia,Belgium,Belgium,France,France,Netherlands,United Kingdom,United Kingdom
Call: Next generation innovative technologies enabling smart grids, storage and energy system integration with increasing share of renewables: distribution network (H2020-LCE-2017-SGS, 2017)
Start date: 2017-12-01
End date: 2020-11-30
Duration (months): 36.0
Total project cost (EUR): 3955258.75
EU funding (EUR): 3955258.75
Participants: 15
Project status: CLOSED

Addressing call topic area 3 (DR Technologies), DRIvE links together cutting edge science in Multi-Agent Systems (MAS), forecasting and cyber security with emerging innovative SMEs making first market penetration in EU DR markets. In doing so, near market solutions are strengthened with lower TRL, higher risk functionalities that support a vision of an “internet of energy” and “collaborative energy network.” From the research side, MAS will move closer to real time operations and progress from a limited number of assets toward decentralized management of a larger number of assets providing DR services to prosumers, grid stakeholders and DSOs. The research will deliver a fully-integrated, interoperable and secure DR Management Platform for Aggregators with advanced hybrid forecasting, optimization, fast-response capabilities and enhanced user participation components in a standard-compliant (Open ADR) market-regulated (USEF) manner, empowering a true cost-effective mass-market (100's millions of heterogenous assets). The project features 5 pilots across 3 countries consisting of a stadium, wind farm, 7-floor office, tertiary & residential buildings within medium-large districts, resulting in over 25 MW of potential flexible capacity. Direct engagement of 100 households and 2 tertiary buildings (over 1,000 persons) is attained and replication to over 75,000 persons is possible. The pilots will be running in real DSO environment with real engagement of grid players. Overall, DRIvE will make available average 20% of load in residential and tertiary buildings for use in DR, resulting in up to 30% cost-saving (price-based DR) and also maximizing revenue for prosumers (incentive-based DR). DRIvE will also allow a minimum 25% increase of renewable hosting capacity (distribution grid) and up to 30% of overall reduction of CAPEX and OPEX costs for DSOs. The project is female led and three women serve in management structure positions of responsibility.

Keywords: demand response,multi agent system flexibility management,blockchain technology
Biopsy equivalent Optical Fiber multifunctional Endoscope (BiOp-FibEnd)

Framework: Horizon 2020 — Excellent Science
Programme: Marie-Sklodowska-Curie Actions
Theme: Marie Skłodowska-Curie
Destination: Individual Fellowships (IF)-Global Fellowships
Action type: Marie Skłodowska-Curie actions
Panel: Information Science and Engineering
Countries involved: Australia,Denmark
Call: Marie Skłodowska-Curie Individual Fellowships (IF-GF) (H2020-MSCA-IF-2015, 2015)
Start date: 2016-06-01
End date: 2020-03-31
Duration (months): 36.0
Total project cost (EUR): 284477.4
EU funding (EUR): 284477.4
Participants: 2
Project status: CLOSED

The BiOp-FibEnd project aims to develop a functional optical fiber for in-vivo examination of suspect tissues. The information obtained is equivalent to that of a biopsy without removing samples from the living body. The main contribution of this technique is to detect earlier, without bringing distress and discomfort to the patient, diseases such as cancer, coronary obstructions, and many others. To this purpose a hyper-lens providing super-resolved imaging in the mid-IR, mid-IR spectroscopy and optical coherence tomography (OCT) will be combined. A fiber endoscope, ready for in-vivo tests, able to observe and get spectroscopy information of living tissues will be realized.

Keywords: super resolved imaging,multifunctional endoscope,mid ir spectroscopy,metamaterials,optical fibers
A new EDD detector will give a knowledge for crystallography with the objective to understand nanostructures and for the development of new materials (EDD Project)

Framework: Horizon 2020 — Industrial Leadership
Programme: Nanotechnologies, Advanced Materials, Advanced Manufacturing and Processing, and Biotechnology
Theme: Nanotechnologies
Action type: SME instrument
Countries involved: France
Call: Accelerating the uptake of nanotechnologies, advanced materials or advanced manufacturing and processing technologies by SMEs (H2020-SMEINST-1-2014, 2014)
Start date: 2015-04-01
End date: 2015-09-30
Duration (months): 6.0
Total project cost (EUR): 71429.0
EU funding (EUR): 50000.0
Participants: 1
Project status: CLOSED

The year 2014 has been proclaimed, by UNESCO, the International Year of Crystallography. Irina Bokova Director-General of UNESCO said : “Crystallography is essential to sustainable development, to tackling global challenges in food, in water, in the environment, in energy, in health. It is by understanding the basic forms of matter that we can transform it for the better, develop new materials, design new drugs against diseases, improve water quality. Development needs innovation, and in most cases, scientific innovation needs crystallography”. Crystallography underpins the development of practically all new materials, from everyday products like computer memory cards to fat television screens, cars and aeroplane components. Crystallographers not only study the structure of materials but can also use this knowledge to modify a structure to give it new properties or to make it behave differently. In fact, crystallography has many applications. EBSD (Electron BackScatter Diffraction) is the technique by which an SEM (Scanning Electron Microscope) can be used to evaluate the micro and nanostructures of a specimen based on crystallographic analysis. EBSD provides absolute crystal orientation information and allows identification of phases and discrimination between phases in materials, texture measurements, boundary characterization and deformation measurements. Today, EBSD is applied across a wide variety of research fields: in the metals processing industry, the aerospace, nuclear, automotive and microelectronics industry, earth sciences etc. The EDD technique is 10 years in advance compared to actual EBSD technique and this new technique will allow the SMEs and materials manufacturers to better understand their crystallography, to uptake of nanostructure modifications under strain, allow the observation of crystallography during the development of new materials and allow the calculation of prediction on the ageing of materials.

Keywords: crystallography,nanostructures,new materials,orientation,sub micron,constraints,ageing,analysis,non destructive
‘Key account management’ for the SME Instrument beneficiaries and ‘Enhancing SME innovation management capacity’ as new proinnovative services for SMEs in the regions of Southern Poland (KAM2SouthPL2)

Framework: Horizon 2020 — Industrial Leadership
Programme: Innovation in SMEs
Action type: Specific Grant agreement
Countries involved: Poland,Poland,Poland,Poland,Poland
Call: H2020 2D CONSULTATION EEN (H2020-EEN-SGA2-2017-2018, 2016)
Start date: 2017-01-01
End date: 2018-12-31
Duration (months): 24.0
Total project cost (EUR): 152835.0
EU funding (EUR): 152835.0
Participants: 9
Project status: CLOSED

The general objective of the project is to contribute to smart growth of Southern regions of Poland by increasing the efficiency and effectiveness of investments in innovation and by contributing to more efficient connection of links along the innovation chain and by this – to contribute to the smart EU growth. The specific objectives of the project are: efficient management of the relation between SME (beneficiary of the SME Instrument) and the coach in purpose to increase the number of projects financed within Horizon 2020 programme completed with a successful commercialization and development of regional SME innovation management capacity: by carrying out innovation management gap analysis, development of the tailored action plan for increasing the effectiveness and efficiency of their innovation management system and implementation of the targeted actions to address bottlenecks and weak points between the innovation capabilities and innovation goals. The objectives will be achieved by performing two kinds of 7-days service packs: Key Account Manager and Enhancing SME innovation management capacity, based on the common for the whole Enterprise Europe Network standard, compliant with European Innovation Management standards - CEN/TS 16555:1. The project is relevant to the Work Programme in Horizon 2020 and helps to overcome lack of capacity in innovation management, recognised as an important barrier in creating economic impact on innovation activities in SMEs. The project is addressed to the specific challenge and scope of the topic, as set out in the Work Programme and offers mentoring and coaching services to beneficiaries who need this help. The project will make SMEs high quality innovation support services available where these are absent or unaffordable on local markets. The project aims at support projects with an European dimension that lead to radical changes in how business (product, processes, services, marketing etc.) is done.

Keywords: innovation,development,sme instrument,horizon 2020,sme innovation coaching,enhancing sme innovation management capacity,innovation strategy,innovation chain,smart growth
Flame nanoengineering for antibacterial medical devices (PROMETHEUS)

Framework: Horizon 2020 — Excellent Science
Programme: European Research Council (ERC)
Theme: European research council
Destination: Starting grants
Action type: ERC actions
Panel: Products and processes engineering
Panel description: Product and process design, chemical, civil, environmental, mechanical, vehicle engineering, energy processes and relevant computational methods
Countries involved: Sweden
Call: ERC Starting Grant (ERC-2017-STG, 2017)
Start date: 2018-03-01
End date: 2023-08-31
Duration (months): 66.0
Total project cost (EUR): 1812500.0
EU funding (EUR): 1812500.0
Participants: 1
Project status: SIGNED

Engineers in nanotechnology research labs have been quite innovative the last decade in designing nanoscale materials for medicine. However, very few of these exciting discoveries are translated to commercial medical products today. The main reasons for this are two inherent limitations of most nanomanufacture processes: scalability and reproducibility. There is too little knowledge on how well the unique properties associated with nanoparticles are maintained during their large-scale production while often poor reproducibility hinders their successful use. A key goal here is to utilize a nanomanufacture process famous for its scalability and reproducibility, flame aerosol reactors that produce at tons/hr commodity powders, and advance the knowledge for synthesis of complex nanoparticles and their direct integration in medical devices. Our aim is to develop the next generation of antibacterial medical devices to fight antimicrobial resistance, a highly understudied field. Antimicrobial resistance constitutes the most serious public health threat today with estimations to become the leading cause of human deaths in 30 years. We focus on flame direct nanoparticle deposition on substrates combining nanoparticle production and functional layer deposition in a single-step with close attention to product nanoparticle properties and device assembly, extending beyond the simple commodity powders of the past. Specific targets here are two devices; a) hybrid drug microneedle patch with photothermal nanoparticles to fight life-threatening skin infections from drug-resistant bacteria and b) smart nanocoatings on implants providing both osteogenic and self-triggered antibacterial properties. The engineering approach for the development of antibacterial devices will provide insight into the basic physicochemical principles to assist in commercialization while the outcome of this research will help the fight against antibiotic resistance improving the public health worldwide.
ScanVid - One-Click Integrated Access to Product-related Digital Content (scanvid)

Framework: Horizon 2020 — Industrial Leadership
Programme: Information and Communication Technologies
Action type: SME instrument
Countries involved: Germany
Call: Open Disruptive Innovation Scheme (H2020-SMEINST-1-2016-2017, 2017)
Start date: 2017-12-01
End date: 2018-05-31
Duration (months): 6.0
Total project cost (EUR): 71429.0
EU funding (EUR): 50000.0
Participants: 1
Project status: CLOSED

ScanVid’s vision is to essentially disrupt the retail market through facilitating consumer’s access to integrated digital information about products, across all phases of the retail lifecycle including pre-sales and after-sales activities. The goal of the proposed SME Instrument Ph. 1 (feasibility study) project (i.e. ScanVidStart) is to perform a technical and business validation of the developed prototype in operational conditions and with the active engagement of a large retailer within established presence worldwide. Along with the successful completion of the feasibility study, the project will systematically study IPR issues, while preparing a detailed business plan for market launch at a global scale.

Keywords: mobile app,barcode scanner,retail,point of sale
Services to enhance innovation management capacities of SMEs in England, Northern Ireland and Wales (ENIW)

Framework: Horizon 2020 — Industrial Leadership
Programme: Innovation in SMEs
Action type: Specific Grant agreement
Countries involved: United Kingdom,United Kingdom,United Kingdom,United Kingdom,United Kingdom,United Kingdom,United Kingdom,United Kingdom,United Kingdom,United Kingdom,United Kingdom,United Kingdom,United Kingdom,United Kingdom,United Kingdom,United Kingdom,United Kingdom,United Kingdom
Call: H2020 2D CONSULTATION EEN (H2020-EEN-SGA2-2017-2018, 2016)
Start date: 2017-01-01
End date: 2018-12-31
Duration (months): 24.0
Total project cost (EUR): 1860235.0
EU funding (EUR): 1860235.0
Participants: 23
Project status: CLOSED

A national service in support of recipients of the H2020 SME Instrument and for the improvement of innovation management in SMEs, with the purpose of more companies with growth potential achieving global scaling Innovation is a vital ingredient of growth and an important element of the future success of the UK. With some 95% of R&D and innovation conducted outside of the UK and many major and lead market shaping companies being of non-UK origin, access to knowledge, markets, skills and partners is increasingly taking place on a global basis. To ensure UK business stays competitive it is important that it is able to effectively access and exploit the growing global investment in research and innovation. Through EEN ENIW activities we will help businesses build collaborations and partnerships and access the finance, knowledge, skills, networks and customers to more rapidly move a concept through to commercialisation and to scale their business.

Keywords: innovation,innovation management,growth,scale up,collaborations,commercialisation,investment,internationalisation,account management,growth showcase,connections,global,markets,partners
Training on Remote Sensing for Ecosystem modElling (TRuStEE)

Framework: Horizon 2020 — Excellent Science
Programme: Marie-Sklodowska-Curie Actions
Theme: Marie Skłodowska-Curie
Destination: Innovative Training Networks (ITN)-European Training Networks
Action type: Marie Skłodowska-Curie actions
Panel: Environment and Geosciences
Countries involved: Italy,Germany,Germany,Spain,Italy,Italy,Belgium,France,Netherlands,Netherlands,United Kingdom,United Kingdom,United Kingdom
Call: Innovative Training Networks (H2020-MSCA-ITN-2016, 2016)
Start date: 2016-10-01
End date: 2020-09-30
Duration (months): 48.0
Total project cost (EUR): 3062364.12
EU funding (EUR): 3062364.12
Participants: 13
Project status: CLOSED

Understanding and predicting ecosystem functions remains a major challenge in evaluating ecosystem services and biophysical controls on biosphere-atmosphere interactions, as current dynamic vegetation models are still not capable of grasping the spatial and temporal variability in ecosystem processes. Remote sensing (RS) data at a range of scales from proximal observations to global extent sampling can detect essential changes in plant traits (PTs), biodiversity and ecosystem functioning, providing a method for scaling-up. However there are still methodological and technical constraints that hamper a systematic incorporation of RS in ecosystem models, including scalability and multi-source data integration issues. TRuStEE will train a new generation of scientists with complementary and interdisciplinary skills in ecosystem modelling, plant physiology, RS technologies and big data analysis, addressing the specific objectives: 1) to identify essential biodiversity variables (EBVs) and the link with PTs and ecosystem functional properties (EFPs), inferable from RS, 2) to investigate a completely new avenue for assessing vegetation photosynthetic efficiency from RS measurements of canopy fluorescence, 3) to assimilate diverse RS data streams with varying spatial and temporal resolution in dynamic ecosystem models and 4) to exploit new satellite missions (e.g. ESA-FLEX, ESA-Sentinels, NASA-GEDI) and EO products for the upscaling of PTs, EBVs and EFPs. The early stage researchers (ESRs) involved will strongly benefit from the network of internationally recognized scientists and private companies with relevant expertise in these topics. The cooperation program proposed will link academic and non-academic participants to allow the circulation of ESRs giving them the opportunity to become new research and innovation leaders in the most cutting edge sophisticated technologies in the field, increasing their employability in both academic and private sectors.

Keywords: remote sensing,unmanned aerial vehicles,essential biodiversity variables,plant trait,ecosystem functional properties,fluorescence,big data,dynamic global vegetation models,earth observation
European Health Data and Evidence Network (EHDEN)

Framework: Horizon 2020 — Societal Challenges
Programme: Health, demographic change and wellbeing
Theme: Public-private partnerships
Destination: Innovative Medicines Initiative 2
Action type: Research and Innovation actions
Partnership: IMI2 (Art-187)
Countries involved: Estonia,Germany,Germany,Spain,Belgium,Switzerland,Switzerland,Belgium,Belgium,Sweden,Sweden,France,France,Czechia,United States,Netherlands,Netherlands,United Kingdom,Portugal,Denmark,United Kingdom,United Kingdom,United Kingdom,United Kingdom
Call: European Health Data Network (EHDN) (H2020-JTI-IMI2-2017-12-two-stage, 2017)
Start date: 2018-11-01
End date: 2024-04-30
Duration (months): 66.0
Total project cost (EUR): 30188808.0
EU funding (EUR): 14105750.0
Participants: 25
Project status: SIGNED

Europe is generating huge amounts of patient-level information contained in Electronic Health Record (EHR) systems and other types of health databases. These include structured data in the form of diagnoses, medications, laboratory test results, etc., and unstructured data in clinical narratives. The Electronic Health Data in a European Network (EHDEN) Consortium leverages these vast volumes of data to improve future clinical practice and individual patient outcomes by increasing our understanding of disease and treatment pathways. EHDEN will galvanize transparent and reproducible analytics that will generate valid real-world evidence to improve patient care, and enable medical outcomes-based research at an unprecedented scale. The EHDEN Consortium provides the infrastructure and eco-system supporting disease-specific projects in the IMI Big Data for Better Outcomes (BD4BO) programme. The core of EHDEN is the use of a common data model (OMOP-CDM), standardised outcome assessment (ICHOM), and transparent open-source analytics (OHDSI). The objective of the EHDEN consortium is to provide all the necessary services that enable a distributed European data network to perform fast, scalable and highly reproducible research, while respecting privacy regulations, local data provenance and governance. This will include services and tools to perform data standardization, analytical pipelines, tools to share study results, and tools for stakeholder engagement and training. The EHDEN Consortium combines active participation of stakeholder representatives with proven experience in: a) integrating different data types, methods and technologies to utilize diverse clinical datasets; b) platform development to make methods and datasets Findable, Accessible, Interoperable and Reusable (FAIR); and c) engaging a wide variety of stakeholders, including health technology assessment agencies, regulators and patients.

Keywords: federated network,ohdsi,fair,omop cdm,ichom,data standardisation,interoperability,open source,personalised medicine,prediction models,machine learning
Chemical probing of transcriptional RAS effectors (ChemRAS)

Framework: Horizon 2020 — Excellent Science
Programme: Marie-Sklodowska-Curie Actions
Theme: Marie Skłodowska-Curie
Destination: Individual Fellowships (IF)-Standard European Fellowships
Action type: Marie Skłodowska-Curie actions
Panel: Life Sciences
Countries involved: Austria
Call: Individual Fellowships (H2020-MSCA-IF-2017, 2017)
Start date: 2019-02-15
End date: 2021-02-14
Duration (months): 24.0
Total project cost (EUR): 178156.8
EU funding (EUR): 178156.8
Participants: 1
Project status: CLOSED

Targeted therapies have been widely used in tumors driven by RAS oncogenes. Unfortunately, no effective RAS inhibitors have been translated to the clinic, and attempts to block other signaling nodes usually fail due to the emergence of drug resistance. Chromatin dependent signal transduction and transcription are a point of confluence of multiple signaling networks elicited by hyperactive RAS. Hence, pharmacologic disruption of gene-regulatory dependencies imposed by mutant RAS represents an attractive therapeutic interface less prone to the emergence of resistances. The urgent clinical need of RAS-related therapies is well exemplified by pancreatic cancer, one of the most aggressive and deadly cancers, which will be the disease background of my studies. Using the innovative approach of targeted protein degradation, I want to characterize and understand the consequences of acute mutant KRAS degradation on chromatin remodeling and transcription. Further engineering the models of acute KRAS degradation will enable to devise cellular reporters of KRAS-dependent chromatin regulation amenable to high-throughput phenotypic drug and genetic screens. Coupled to a facile readout via high-throughput microscopy, these screens will allow me to identify molecules and genetic perturbations that interfere with KRAS-dependent, transcriptionally active chromatin. Lead molecules will be characterized for the underpinning mechanism of action and assessed for therapeutic potential. Building on already existing experimental and computational pipelines in the Winter laboratory at CeMM-Research Center for Molecular Medicine of the Austrian Academy of Sciences, this project will increase the understanding of transcriptional control elicited by oncogenic KRAS and could open new avenues for the treatment of RAS-driven tumors based on chemical modulation of critical chromatin and transcription regulators.

Keywords: chemical genetics,targeted protein degradation,cancer,mutant ras signaling,drug screens,crispr,cas9 screens